Study on US Drug Manufacturing Barriers: Aiming for Lower Costs, Better Access
This act aims to investigate what hinders drug production in the United States. The goal is to understand why building new drug factories is expensive and time-consuming, and what makes the US less competitive than other countries. The study's findings are intended to help streamline regulations, potentially leading to greater drug availability and lower prices for citizens.
Key points
A study will be conducted to identify obstacles to expanding or building new drug manufacturing facilities in the US.
The study will assess whether environmental or other regulations delay and increase costs for drug production compared to other countries.
The goal is to find ways to streamline regulations to increase domestic drug manufacturing, potentially improving supply chain security and drug accessibility.
Status:
Introduced
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens
(explained here).
Start recording it now.